
Medlords Gyanchand Pharmaceutical Private Limited
Founded in March 2025 and headquartered in Bihar, India.
Founded in March 2025 and headquartered in Bihar, India.
Medlords Gyanchand Pharmaceutical Private Limited (MGPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2025 ( one month 7 days old ). Its registered office is in Patna, Bihar, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Pratyush Kumar and Puja Kumari serve as directors at the Company.
Patna, Bihar, India
+91-XXXXXXXXXX
U47721BR2025PTC074109
074109
Private Limited Indian Non-Government Company
02 Mar 2025
-
-
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pratyush Kumar ![]() | Director | 02-Mar-2025 | Current |
Puja Kumari ![]() | Director | 02-Mar-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Medlords Gyanchand Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Pratyush Kumar and Puja Kumari are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medlords Gyanchand Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medlords Gyanchand Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlords Gyanchand Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pratyush Kumar was appointed as a Director was appointed as a Director on 02 Mar 2025 & has been associated with this company since 1 month 7 days .
Puja Kumari was appointed as a Director was appointed as a Director on 02 Mar 2025 & has been associated with this company since 1 month 7 days .
Medlords Gyanchand Pharmaceutical Private Limited was registered on 02 Mar 2025 with Roc Patna & aged 1 month 7 days as per MCA records.
Medlords Gyanchand Pharmaceutical Private Limited was incorporated on 02 Mar 2025.
The authorized share capital of Medlords Gyanchand Pharmaceutical Private Limited is ₹ 0.10 M and paid-up capital is ₹ 50.00 K .
Currently 2 directors are associated with Medlords Gyanchand Pharmaceutical Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medlords Gyanchand Pharmaceutical Private Limited is 21 A Road No 11 Indrapuri Patliputra, Patna India, Phulwari, Bihar, 800024.
The corporate identification number (CIN) of Medlords Gyanchand Pharmaceutical Private Limited is U47721BR2025PTC074109 and the company number is 074109 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.